abiraterone mylan
mylan ireland limited - abirateroniasetaatti - prostatiset kasvaimet - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
capecitabin fair-med 150 mg tabletti, kalvopäällysteinen
fair-med healthcare gmbh - capecitabinum - tabletti, kalvopäällysteinen - 150 mg - kapesitabiini
capecitabin fair-med 500 mg tabletti, kalvopäällysteinen
fair-med healthcare gmbh - capecitabinum - tabletti, kalvopäällysteinen - 500 mg - kapesitabiini
ictastan 200 mg / 245 mg tabletti, kalvopäällysteinen
actavis group ptc ehf - tenofoviri disoproxili succinas,emtricitabinum - tabletti, kalvopäällysteinen - 200 mg / 245 mg - tenofoviiridisoproksiili ja emtrisitabiini
darunavir sandoz 75 mg tabletti, kalvopäällysteinen
sandoz a/s sandoz a/s - darunavirum - tabletti, kalvopäällysteinen - 75 mg - darunaviiri
sunitinib sandoz 12.5 mg kapseli, kova
sandoz a/s - sunitinib - kapseli, kova - 12.5 mg - sunitinibi
sunitinib sandoz 25 mg kapseli, kova
sandoz a/s - sunitinib - kapseli, kova - 25 mg - sunitinibi
sunitinib sandoz 37.5 mg kapseli, kova
sandoz a/s - sunitinib - kapseli, kova - 37.5 mg - sunitinibi
sunitinib sandoz 50 mg kapseli, kova
sandoz a/s - sunitinib - kapseli, kova - 50 mg - sunitinibi
dasatinib sandoz 100 mg tabletti, kalvopäällysteinen
sandoz a/s sandoz a/s - dasatinibum - tabletti, kalvopäällysteinen - 100 mg - dasatinibi